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Although the need to review the ethics of research
conducted in humans is generally accepted, there is less
agreement over the extent to which reviewers are responsible
or answerable for the decisions they make. What is the
nature of reviewer accountability? RECs, like their US and
Canadian counterparts (institutional review boards and
research ethics boards, respectively), are responsible for
assessing human research protocols for conformity to ethical
principles. (For the purposes of this commentary, the term
‘REC’ will be used to refer to research ethics committees,
institutional review boards and research ethics boards.) This
role is currently strained by increases in the number of
protocols that are in need of review, the scientific and
funding complexities of the protocols [1,2], and a lack of
clear standards for assessment of ethics [3]. To maintain or,
in many cases, to restore public and professional trust in the
ethics of human research, such as that done in critical care
units, it is imperative that steps be taken to clarify the
accountability of RECs and their individual members.
Attempting to learn from our past
Although human research has yielded phenomenal health
and social benefits, the global scientific community has an
unfortunate track record of harmful and exploitative research
studies, in which the welfare of participants was sacrificed to
competing interests of the investigators (for reviews of cases
see Katz [4], Jones [5] and Weijer [6]). In recent years, even
in some of the world’s most prestigious research centres
there have been many examples of noncompliance with
ethical principles, resulting in preventable serious adverse
events and inappropriate recruiting of subjects [7].
Since World War II there have been several attempts, at both
national and international levels [8–13], to articulate ethical
principles for the conduct of research that involves humans.
These codes and guidelines typically call upon RECs to
approve, reject, or demand modifications to protocols
reviewed. In order to fulfil this mandate RECs must assess
whether the research protocols demonstrate the following:
sound scientific method and design; acceptable balance
between risk of harm and probability of benefit; importance of
scientific objective; adequate procedures to ensure that
consent is informed and voluntary; protection of
confidentiality; equitable selection of subjects; and adequate
protection of vulnerable subjects. Although these principles
and requirements are intended to be standards against which
protocols are assessed, existing codes and guidelines
include few provisions that ensure adequacy of the REC
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review process or reasonable application of principles. They
are especially vague regarding how to weigh risks and
benefits. The quality [14,15] of a REC’s work depends
largely on the values, conscience and commitment of its
volunteer members [16].
Context for the physician research ethics
committee member
Critical care physicians considering involvement in an REC
may wonder what their liability might be for committee
decisions. To date, courts have provided little useful
guidance on the standard of accountability to which REC
members can be held [17]. The standard of care that REC
members are likely to have to meet is that of the reasonable
REC member. That standard might vary from individual to
individual, depending on the expertise of the member in the
particular area under review. Those members with a greater
degree of relevant expertise might be held to a higher
standard of care [18]. Although REC members often undergo
some form of education regarding research ethics,
membership in a REC does not require that each member be
an expert in research ethics. The current system is based on
the presumption that decisions of appropriately constituted
RECs will reflect thorough consideration of all relevant
issues. Also, RECs do not serve as legal counsel for principal
investigators. A lawyer is typically among the members of the
REC in order to ensure that the law is appropriately included
as one of several morally relevant factors that must be
considered in REC deliberations.
It would be prudent for physicians serving on institutional
RECs to satisfy themselves that the hospital or organization
that they are serving will provide them with full defence and
legal protection in the event that legal challenges arise from
that role.
Looking to the future
The relationship between RECs and researchers can
sometimes be quite divisive. The advancement of ethical
research is curtailed if the efforts of RECs are perceived by
well meaning researchers to be antiscientific and irrelevant
hurdles over which they must needlessly jump. It is in
everyone’s interest to promote the perspective that the
RECs, as well as the researchers themselves, have roles in
protecting the safety of people participating in medical
research studies.
The doctor–patient relationship is intended to be one of trust
and confidence. Aspects of it have long been recognized in
ethics and law as fiduciary in nature [19]. This means that
doctors have an obligation to their patients to act with utmost
good faith and loyalty, and must never allow their personal
interests to conflict [20] with their professional duty (for a
description of the general principles underlying fiduciary
relationships, see [21]). This fiduciary relationship should not
be abandoned when physicians and patients are involved in
research. This fiduciary relationship should even be extended
to RECs that are set up to protect individuals who participate
in medical research [22].
The accountability of RECs may be clarified in a number of
ways: statutory codification of detailed standards; an
enhanced model of self-regulation; accreditation of RECs;
and certification of REC members. Whether a single strategy
or a combination of strategies is pursued, the goal should be
to reinforce of the professionalism of human research review
[23] in ways that acknowledge the separate [24–26] as well
as the collective responsibilities of researchers and RECs. By
specifying how relevant ethical principles are to be applied in
REC deliberations, the procedures that RECs must adhere to
in reviewing protocols and the level of expertise expected of
each member, the overall accountability of RECs will be
clarified and more transparent.
Conclusion
While the new millennium is well underway and we look
forward to the health benefits that human research aims to
achieve, we must take warning from the mistakes of the past.
Vague notions of accountability, although well meaning and
sentimental, offer little guidance to those they are intended to
direct and little comfort to those they are intended to protect.
Given the increasing pressures that face RECs in terms of
volume of work and complexity of both protocols and funding
relationships, it is imperative that the clarification of the roles
and responsibilities of RECs is not delayed. One need not
look far back to be reminded of the dangers of inadequate
review processes or inappropriate risk–benefit analysis. For
REC members, researchers, subjects and the public at large
to have justifiable confidence in the ethics of human research
and the role of RECs in reviewing protocols, issues of
accountability will first have to be clarified.
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